Crossmark

Baseline Findings of PreventE4: A Double-Blind Placebo Controlled Clinical Trial Testing High Dose DHA in APOE4 Carriers before the Onset of Dementia

Crossref DOI link: https://doi.org/10.14283/jpad.2023.77

Published Print: 2023-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Yassine, Hussein

Arellanes, I.C.

Mazmanian, A.

De La Cruz, L.

Martinez, J.

Contreras, L.

Kono, N.

Liu, B.S.

Badie, D.

Bantugan, M.A.

Grindon, A.

Urich, T.

D'Orazio, L.

Emmanuel, B.A.

Chui, H.C.

Mack, W.J.

Harrington, M.G.

Braskie, M.N.

Schneider, L.S.
License Information

Text and Data Mining valid from 2023-11-01

Text and Data Mining valid from 2023-11-01

Version of Record valid from 2023-06-19
More Information

This article is maintained by: Elsevier

Article Title: Baseline Findings of PreventE4: A Double-Blind Placebo Controlled Clinical Trial Testing High Dose DHA in APOE4 Carriers before the Onset of Dementia

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2023.77

Content Type: article

Copyright: Copyright © 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS